Mitochondrial Coenzyme Q10 Delivery Improves Energy Production in Rat Cardiac Myoblasts and Duchenne Muscular Dystrophy Model Rat Cardiomyocytes
Biological and Pharmaceutical Bulletin · 2025
DOI: 10.1248/bpb.b25-00327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Itsumi Sato und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan. Hauptthemen laut MEDLINE: Ubiquinone, Muscular Dystrophy, Duchenne, Myocytes, Cardiac, Myoblasts, Cardiac. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Enhancing cardiomyocyte mitochondrial function has been reported as a potential therapeutic approach for various diseases. However, this is technically difficult, and its practical use has not been described. Although treatments such as exon skipping for skeletal muscle have been established for Duchenne muscular dystrophy (DMD), no curative treatment has been developed for DMD cardiomyopathy, and only cardioprotective medications and symptomatic treatments are available. In this study, we attempted to activate cardiac myocyte mitochondria via direct drug delivery using lipid nanoparticles and investigated the application of this strategy to diseased cells. First, we delivered CoQ10, a mitochondrial activator with cellular antioxidant capacity, into mitochondria in H9C2 cells using MITO-Porter, a mitochondria-directed nanoparticle. Cellular MITO-Porter uptake was measured using flow cytometry. Co-localization of mitochondria and MITO-Porter was confirmed using confocal laser microscopy. Mitochondrial respiratory capacity was measured using an extracellular flux analyzer. Furthermore, the concentration-response relationships of the amount of nanoparticles or CoQ10 with mitochondrial energy production capacity were confirmed. Next, we examined the possibility of improving mitochondrial energy production capacity in diseased cells. Cells were isolated from the myocardium of DMD model rats generated using the CRISPR-Cas9 system. Mitochondrial energy production capacity was lower in DMD primary cardiomyocytes than in wild-type primary cardiomyocytes. CoQ10 delivery to mitochondria in DMD primary cardiomyocytes using MITO-Porter improved mitochondrial energy production capacity. Thus, enhanced cardiomyocyte mitochondrial energy production might represent a potential treatment for cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.
- Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-0812, Japan.
- Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.
- Fusion Oriented Research for Disruptive Science and Technology (FOREST) Program, Japan Science and Technology Agency (JST) Japan, Saitama 332-0012, Japan.
Zitieren
APA
Sato, I., Sasaki, D., Abe, J., Yamanouchi, K., Takeda, A., & Yamada, Y. (2025). Mitochondrial Coenzyme Q10 Delivery Improves Energy Production in Rat Cardiac Myoblasts and Duchenne Muscular Dystrophy Model Rat Cardiomyocytes. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00327
Vancouver
Sato I, Sasaki D, Abe J, Yamanouchi K, Takeda A, Yamada Y. Mitochondrial Coenzyme Q10 Delivery Improves Energy Production in Rat Cardiac Myoblasts and Duchenne Muscular Dystrophy Model Rat Cardiomyocytes. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00327
BibTeX
@article{Sato2025,
author = {Sato, Itsumi and Sasaki, Daisuke and Abe, Jiro and Yamanouchi, Keitaro and Takeda, Atsuhito and Yamada, Yuma},
title = {Mitochondrial Coenzyme Q10 Delivery Improves Energy Production in Rat Cardiac Myoblasts and Duchenne Muscular Dystrophy Model Rat Cardiomyocytes},
journal = {Biological and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/bpb.b25-00327}
}
EUVIMED